4-methyl-4-aza-3-oxopregnane-20-carboxylate has been researched along with dihydrotestosterone in 6 studies
Studies (4-methyl-4-aza-3-oxopregnane-20-carboxylate) | Trials (4-methyl-4-aza-3-oxopregnane-20-carboxylate) | Recent Studies (post-2010) (4-methyl-4-aza-3-oxopregnane-20-carboxylate) | Studies (dihydrotestosterone) | Trials (dihydrotestosterone) | Recent Studies (post-2010) (dihydrotestosterone) |
---|---|---|---|---|---|
12 | 0 | 0 | 9,325 | 307 | 1,517 |
Protein | Taxonomy | 4-methyl-4-aza-3-oxopregnane-20-carboxylate (IC50) | dihydrotestosterone (IC50) |
---|---|---|---|
Plasma kallikrein | Homo sapiens (human) | 0.0031 | |
Glucocorticoid receptor | Homo sapiens (human) | 0.54 | |
Sex hormone-binding globulin | Homo sapiens (human) | 0.0038 | |
Progesterone receptor | Oryctolagus cuniculus (rabbit) | 0.44 | |
Progesterone receptor | Homo sapiens (human) | 7.3 | |
Mineralocorticoid receptor | Homo sapiens (human) | 0.36 | |
Sex hormone-binding globulin | Rattus norvegicus (Norway rat) | 0.023 | |
Androgen receptor | Homo sapiens (human) | 0.0048 | |
Androgen receptor | Rattus norvegicus (Norway rat) | 0.4041 | |
Androgen receptor | Mus musculus (house mouse) | 0.001 | |
Mineralocorticoid receptor | Rattus norvegicus (Norway rat) | 2.1 | |
Testosterone 17-beta-dehydrogenase 3 | Homo sapiens (human) | 0.0026 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (50.00) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lemmi, CA; Ngyuen, MM; Rajfer, J | 1 |
Murono, EP | 1 |
Kadohama, N; Karr, JP; Kim, U; Murphy, GP; Sandberg, AA; Wakisaka, M | 1 |
Kadohama, N; Karr, JP; Murphy, GP; Sandberg, AA | 1 |
Brooks, JR; Liang, T; Rasmusson, GH | 1 |
Ahmed, S; Denison, S | 1 |
6 other study(ies) available for 4-methyl-4-aza-3-oxopregnane-20-carboxylate and dihydrotestosterone
Article | Year |
---|---|
Effect of 5-alpha-reductase inhibitor, 4-MAPC, on testicular descent in male rat.
Topics: 5-alpha Reductase Inhibitors; Animals; Animals, Newborn; Azasteroids; Dihydrotestosterone; Male; Pregnanes; Rats; Rats, Inbred Strains; Testis; Testosterone | 1991 |
Differential regulation of steroidogenic enzymes metabolizing testosterone or dihydrotestosterone by human chorionic gonadotropin in cultured rat neonatal interstitial cells.
Topics: 17-Hydroxysteroid Dehydrogenases; 3-Hydroxysteroid Dehydrogenases; 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Animals; Animals, Newborn; Azasteroids; Cells, Cultured; Chorionic Gonadotropin; Dihydrotestosterone; Leydig Cells; Male; Pregnanes; Rats; Rats, Inbred Strains; Testosterone | 1990 |
Retardation of prostate tumor progression in the Noble rat by 4-methyl-4-aza-steroidal inhibitors of 5 alpha-reductase.
Topics: 5-alpha Reductase Inhibitors; Animals; Azasteroids; Castration; Dihydrotestosterone; Male; Organ Size; Oxidoreductases; Pregnanes; Prostate; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Steroids, Heterocyclic | 1985 |
Selective inhibition of prostatic tumor 5 alpha-reductase by a 4-methyl-4-azasteroid.
Topics: 5-alpha Reductase Inhibitors; Animals; Azasteroids; Cell Nucleus; Cytosol; Dihydrotestosterone; Humans; Kinetics; Male; Organ Culture Techniques; Oxidoreductases; Pregnanes; Prostate; Prostatic Neoplasms; Rats; Rats, Inbred WF; Steroids, Heterocyclic; Testosterone | 1984 |
12. Androgens: Pharmacodynamics and antagonists. Biochemical and biological studies with 4-aza-steroidal 5 alpha-reductase inhibitors.
Topics: 5-alpha Reductase Inhibitors; Animals; Azasteroids; Binding, Competitive; Dihydrotestosterone; Kinetics; Male; Oxidoreductases; Pregnanes; Prostate; Rats; Receptors, Androgen; Steroids, Heterocyclic; Structure-Activity Relationship | 1983 |
Mechanism based representation of the active site of 5 alpha-reductase (5AR).
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Azasteroids; Binding Sites; Dihydrotestosterone; Enzyme Inhibitors; Finasteride; Models, Chemical; Models, Molecular; NADP; Pregnanes; Structure-Activity Relationship; Testosterone | 1998 |